Status:
COMPLETED
Effect of the Dietary Supplement SAMe on Blood Homocysteine Levels
Lead Sponsor:
Mayo Clinic
Conditions:
Heart Disease
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if the oral intake of the dietary supplement SAMe increases blood homocysteine levels in healthy human subjects.
Detailed Description
S-adenosyl-L-methionine (SAMe or AdoMet) is a commonly used nutritional supplement available in the United States since 1999. SAMe is metabolized to homocysteine, a known cardiovascular risk factor. N...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Women and men age 18 - 65
- Able to understand and sign a consent form
- Exclusion criteria:
- Smoking
- Pregnant or lactating
- Women actively trying to conceive
- Diagnosis of panic disorder or bipolar disorder
Exclusion
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00284011
Start Date
June 1 2005
End Date
May 1 2006
Last Update
January 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905